Agile Therapeutics (AGRX) PT Lowered to $5 at RBC Capital
Get Alerts AGRX Hot Sheet
Price: $0.60 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 18
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 18
Join SI Premium – FREE
RBC Capital analyst Daniel Busb lowered the price target on Agile Therapeutics (NASDAQ: AGRX) to $5.00 (from $6.00) while maintaining a Outperform rating.
You May Also Be Interested In
- VinFast Auto Ltd. (VFS) PT Lowered to $5 at BTIG
- Travelers (TRV) PT Lowered to $202 at Goldman Sachs
- Lundin Mining Corp. (LUN:CN) (LUNMF) PT Raised to Cdn$15 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!